Eliud Sepulveda

1.1k total citations · 1 hit paper
10 papers, 801 citations indexed

About

Eliud Sepulveda is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Eliud Sepulveda has authored 10 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in Eliud Sepulveda's work include Mycobacterium research and diagnosis (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Cancer therapeutics and mechanisms (1 paper). Eliud Sepulveda is often cited by papers focused on Mycobacterium research and diagnosis (5 papers), Tuberculosis Research and Epidemiology (4 papers) and Cancer therapeutics and mechanisms (1 paper). Eliud Sepulveda collaborates with scholars based in United States, Canada and Germany. Eliud Sepulveda's co-authors include Keith A. Canada, Herbert Nar, Felix Schiele, Tobias Litzenburger, John Park, Joanne van Ryn, Chinnaswamy Jagannath, Jeffrey K. Actor, Robert L. Hunter and Audrey Wanger and has published in prestigious journals such as Blood, Infection and Immunity and Virology.

In The Last Decade

Eliud Sepulveda

10 papers receiving 778 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A specific antidote for dabigatran: functional and structural characterization

2013 430 citations Felix Schiele, Joanne van Ryn et al. Blood profile →

Peers

Countries citing papers authored by Eliud Sepulveda

Since Specialization

Citations

This map shows the geographic impact of Eliud Sepulveda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eliud Sepulveda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eliud Sepulveda more than expected).

Fields of papers citing papers by Eliud Sepulveda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eliud Sepulveda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eliud Sepulveda. The network helps show where Eliud Sepulveda may publish in the future.

Co-authorship network of co-authors of Eliud Sepulveda

This figure shows the co-authorship network connecting the top 25 collaborators of Eliud Sepulveda. A scholar is included among the top collaborators of Eliud Sepulveda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eliud Sepulveda. Eliud Sepulveda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Selective targeting of the IL23 pathway: Generation and characterization of a novel high-affinity humanized anti-IL23A antibody 2015 ·mAbs ·Sanjaya Singh, Rachel Kroe‐Barrett, Keith A. Canada, (unknown), Eliud Sepulveda, (unknown), (unknown), Ernest Raymond, Jennifer Ahlberg, Lee Frego, (unknown), (unknown), David H. Presky, Jeffrey H. Hanke	94
2	Neutralizing antibodies are unable to inhibit direct viral cell-to-cell spread of human cytomegalovirus 2013 ·Virology ·(unknown), Louie Lamorte, Eliud Sepulveda, Ivo C. Lorenz, Annick Gauthier, Michael Franti	33
3	A specific antidote for dabigatran: functional and structural characterization breakdown → 2013 ·Blood ·Felix Schiele, Joanne van Ryn, Keith A. Canada, (unknown), Eliud Sepulveda, John Park, Herbert Nar, Tobias Litzenburger	430
4	A Mutant of Mycobacterium tuberculosis H37Rv That Lacks Expression of Antigen 85A Is Attenuated in Mice but Retains Vaccinogenic Potential 2004 ·Infection and Immunity ·(unknown), Eliud Sepulveda, Lisa Y. Armitige, Jeffrey K. Actor, Audrey Wanger, Steven J. Norris, Robert L. Hunter, Chinnaswamy Jagannath	45
5	Decreased Infectivity despite Unaltered C3 Binding by a ΔhbhAMutant ofMycobacterium tuberculosis 2002 ·Infection and Immunity ·Stacey L. Mueller‐Ortiz, Eliud Sepulveda, Margaret Olsen, Chinnaswamy Jagannath, Audrey Wanger, Steven J. Norris	25
6	Identification of viable and non-viable Mycobacterium tuberculosis in mouse organs by directed RT-PCR for antigen 85B mRNA 2000 ·Microbial Pathogenesis ·(unknown), Jeffrey K. Actor, Eliud Sepulveda, R. L. Hunter, Chinnaswamy Jagannath	51
7	Effect of poloxamer CRL-1072 on drug uptake and nitric-oxide-mediated killing of Mycobacterium avium by macrophages 2000 ·Immunopharmacology ·Chinnaswamy Jagannath, Eliud Sepulveda, Jeffrey K. Actor, (unknown), (unknown), Robert L. Hunter	8
8	Hypersusceptibility of A/J Mice to Tuberculosis is in Part Due to a Deficiency of the Fifth Complement Component (C5) 2000 ·Scandinavian Journal of Immunology ·Chinnaswamy Jagannath, Harald Hoffmann, Eliud Sepulveda, Jeffrey K. Actor, Rick A. Wetsel, Robert L. Hunter	49
9	Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer 1999 ·Life Sciences ·Chinnaswamy Jagannath, Alice Wells, (unknown), Margaret Olsen, Eliud Sepulveda, (unknown), Robert L. Hunter, Amitava Dasgupta	20
10	Detection of antibodies against Streptococcus suis capsular type 2 using a purified capsular polysaccharide antigen-based indirect ELISA 1996 ·Veterinary Microbiology ·Eliud Sepulveda, Eleonora Altman, M. Kobisch, S. D’Allaire, Marcelo Gottschalk	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact